BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 31722562)

  • 1. Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications.
    Dal Canto E; Ceriello A; Rydén L; Ferrini M; Hansen TB; Schnell O; Standl E; Beulens JW
    Eur J Prev Cardiol; 2019 Dec; 26(2_suppl):25-32. PubMed ID: 31722562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular disease in diabetes type 2: current concepts.
    Rosengren A
    J Intern Med; 2018 Sep; 284(3):240-253. PubMed ID: 29923339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of type 2 diabetes and its complications in India and economic costs to the nation.
    Pradeepa R; Mohan V
    Eur J Clin Nutr; 2017 Jul; 71(7):816-824. PubMed ID: 28422124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The global burden of diabetes and its complications: an emerging pandemic.
    van Dieren S; Beulens JW; van der Schouw YT; Grobbee DE; Neal B
    Eur J Cardiovasc Prev Rehabil; 2010 May; 17 Suppl 1():S3-8. PubMed ID: 20489418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic importance of visit-to-visit blood pressure variability for micro- and macrovascular outcomes in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Salles GF
    Cardiovasc Diabetol; 2020 May; 19(1):50. PubMed ID: 32359350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of the ankle-brachial index on the development of micro- and macrovascular complications in individuals with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Melo JV; Salles GC; Leite NC; Salles GF
    Diabetologia; 2018 Nov; 61(11):2266-2276. PubMed ID: 30112690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diabetes and cardiovascular complications].
    Resl M; Clodi M
    Wien Med Wochenschr; 2010 Jan; 160(1-2):3-7. PubMed ID: 20229155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global trends in diabetes complications: a review of current evidence.
    Harding JL; Pavkov ME; Magliano DJ; Shaw JE; Gregg EW
    Diabetologia; 2019 Jan; 62(1):3-16. PubMed ID: 30171279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Polish Multicenter Study on Diabetes Epidemiology (PMSDE)--1998-2000].
    Szybiński Z
    Pol Arch Med Wewn; 2001 Sep; 106(3):751-8. PubMed ID: 11928582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does microvascular disease predict macrovascular events in type 2 diabetes?
    Rosenson RS; Fioretto P; Dodson PM
    Atherosclerosis; 2011 Sep; 218(1):13-8. PubMed ID: 21763654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Social Network Characteristics Are Associated With Type 2 Diabetes Complications: The Maastricht Study.
    Brinkhues S; Dukers-Muijrers NHTM; Hoebe CJPA; van der Kallen CJH; Koster A; Henry RMA; Stehouwer CDA; Savelkoul PHM; Schaper NC; Schram MT
    Diabetes Care; 2018 Aug; 41(8):1654-1662. PubMed ID: 29907582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interpreting global trends in type 2 diabetes complications and mortality.
    Ali MK; Pearson-Stuttard J; Selvin E; Gregg EW
    Diabetologia; 2022 Jan; 65(1):3-13. PubMed ID: 34837505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eye complications and markers of morbidity and mortality in long-term type 1 diabetes.
    Grauslund J
    Acta Ophthalmol; 2011 Feb; 89 Thesis 1():1-19. PubMed ID: 21443578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Chronic Complications, Their Risk Factors, and the Cardiovascular Risk Factors among Patients with Type 2 Diabetes Attending the Diabetic Clinic at a Tertiary Care Hospital in Sri Lanka.
    Arambewela MH; Somasundaram NP; Jayasekara HBPR; Kumbukage MP; Jayasena PMS; Chandrasekara CMPH; Fernando KRAS; Kusumsiri DP
    J Diabetes Res; 2018; 2018():4504287. PubMed ID: 29951551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of socioeconomic status and gender on glycaemic control, cardiovascular risk factors and diabetes complications in type 1 and 2 diabetes: a population based analysis from a Scottish region.
    Collier A; Ghosh S; Hair M; Waugh N
    Diabetes Metab; 2015 Apr; 41(2):145-51. PubMed ID: 25454092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Burden of Diabetes: Emerging Data.
    Maffi P; Secchi A
    Dev Ophthalmol; 2017; 60():1-5. PubMed ID: 28427059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of disease and costs associated with type 2 diabetes in emerging and established markets: systematic review analyses.
    Alzaid A; Ladrón de Guevara P; Beillat M; Lehner Martin V; Atanasov P
    Expert Rev Pharmacoecon Outcomes Res; 2021 Aug; 21(4):785-798. PubMed ID: 32686530
    [No Abstract]   [Full Text] [Related]  

  • 18. A profile of diabetes in Pacific Island Countries and Territories.
    Tin ST; Lee CM; Colagiuri R
    Diabetes Res Clin Pract; 2015 Feb; 107(2):233-46. PubMed ID: 25467624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in micro- and macro-vascular complications of diabetes mellitus.
    Maric-Bilkan C
    Clin Sci (Lond); 2017 May; 131(9):833-846. PubMed ID: 28424377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approaches to prevention of cardiovascular complications and events in diabetes mellitus.
    Coccheri S
    Drugs; 2007; 67(7):997-1026. PubMed ID: 17488145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.